key: cord-0867538-un2n0qig
authors: Fan, Yihua; Liu, Wei; Jin, Yue; Hou, Xu; Zhang, Xuewu; Pan, Hudan; Lu, Hang; Guo, Xiaojing
title: Integrated Molecular Docking with Network Pharmacology to Reveal the Molecular Mechanism of Simiao Powder in the Treatment of Acute Gouty Arthritis
date: 2021-04-27
journal: Evid Based Complement Alternat Med
DOI: 10.1155/2021/5570968
sha: 9917385ff67cdceaabe5517b9fb9a9884390c587
doc_id: 867538
cord_uid: un2n0qig

BACKGROUND: The incidence of gout has been rapidly increasing in recent years with the changing of diet. At present, modern medications used in the clinical treatment of gout showed several side effects, such as gastrointestinal damage and the increased risk of cardiovascular disease. The traditional Chinese prescription Simiao Powder (SMP) has a long history in the treatment of acute gouty arthritis (AGA) and has a good curative effect. However, the mechanism and target of its therapeutic effects are still not completely understood. METHODS: Potential active compounds (PACs) and targets of SMP were found in the TCMSP database, and the disease target genes related to AGA were obtained by searching CTD, DisGeNET, DrugBank, GeneCards, TTD, OMIM, and PharmGKB disease databases with “acute gouty arthritis” and “Arthritis, Gouty” as keywords, respectively. The network of “Traditional Chinese medicine (TCM)-PACs-potential targets of acute gouty arthritis” was constructed with the Cytoscape 3.7.2 software, and the target genes of acute gouty arthritis were intersected with genes regulated by active compounds of SMP. The resultant common gene targets were input into Cytoscape 3.7.2 software, and the BisoGenet plug-in was used to construct a PPI network. The GO functional enrichment analysis and KEGG pathway enrichment analysis of the intersecting target proteins were performed using R software and corresponding program packages. The molecular docking verification was carried out between the potentially active compounds of SMP and the core target at the same time. RESULTS: 40 active components and 203 targets were identified, of which 95 targets were common targets for the drugs and diseases. GO function enrichment analysis revealed that SMP regulated several biological processes, such as response to lipopolysaccharide and oxidative stress, RNA polymerase II transcription regulator complex, protein kinase complex, and other cellular and molecular processes, including DNA-binding transcription factor binding. Results of KEGG pathway analysis showed that SMP was associated with AGA-related pathways such as interleukin-17 (IL-17), tumor necrosis factor (TNF), p53, and hypoxia-inducible factor 1 (HIF-1) signaling pathways. The results of molecular docking showed that active compounds in SMP exhibited strong binding to five core protein receptors (TP53, FN1, ESR1, CDK2, and HSPA5). CONCLUSIONS: Active components of SMP, such as quercetin, kaempferol, wogonin, baicalein, beta-sitosterol, and rutaecarpine, showed therapeutic effects on AGA. These compounds were strongly associated with core target proteins (such as TP53, FN1, ESR1, CDK2, and HSPA5). This study reveals that IL-17, TNF, p53, and HIF-1 signaling pathways mediate the therapeutic effects of SMP on AGA. These findings expand our understanding of the mechanism of SMP in the treatment of AGA.

Gouty arthritis (GA) is characterized by acute onset of single joint redness, swelling, heat, and pain at night or in the morning. e pain progressively worsens, and in severe cases, patients often suffer from cutting pain, which often reaches a peak within 24 hours [1] . e number of gout patients has increased drastically due to dietary changes and high intake of high-purine foods and beer [2] . According to the gout epidemic survey in Hong Kong, the prevalence of gout increased from 1.56% in 2006 to −2.92% in 2016 [3] . In the United States, the prevalence of gout was about 3.9% in 2016, with an estimated 9.2 million gout patients [4] . Acute gouty arthritis (AGA) is the first symptom of gout. Severe pain can reduce the quality of life of patients. Recurrent acute arthritis can destroy joints and damage internal organs [5] . Gout treatment guidelines issued in 2012 by the American College of Rheumatology (ACR) recommend nonsteroidal anti-inflammatory drugs (NSAIDs) or oral colchicine for acute attacks of gout [6] . It has been reported that NSAIDs are harmful to the gastrointestinal tract, liver, and kidney, central nervous system, etc. [7] . Colchicine is an anti-inflammatory drug commonly used in the treatment of acute gout. However, when taken in large doses, it easily causes gastrointestinal tract discomfort, liver and kidney damage, or heart disease. Meanwhile, it may lead to poisoning in elderly patients [8] .

erefore, safer and more effective drugs for the treatment of AGA are urgently needed.

Simiao Powder (SMP) is a well-known prescription used in ancient China for the treatment of joint pain [9] . is prescription originated from Chengfang Biandu in the Qing Dynasty (1904 A.D.) . SMP is composed of Rhizoma Atractylodis (Cang Zhu), Cortex Phellodendri (Huang Bo) , Radix Vladimiriae (Niu Xi), and Semen Coicis (Yi Yi Ren), and it could clear heat, dry dampness, and promote blood circulation to invigorate the tendons. In the gouty arthritis model, Lin et al. revealed that SMP treatment could effectively relieve joint symptoms and improve laboratory indexes (e.g., serum uric acid content or inflammatory cytokines IL-1b, IL-9, IFNg, and so on). Moreover, the anti-inflammatory effect of SMP was stronger than febuxostat [10] . A systematic review and meta-analysis demonstrated that SMP possesses anti-inflammatory, analgesic, and uric acid-lowering effects and hence can treat AGA. Jiawei reported that SMP is superior to other anti-inflammatory drugs or combined uric acid-lowering drugs. Compared to modern medications, SMP is associated with fewer adverse events [11] . However, the mechanism and the therapeutic target of SMP in the management of AGA are vague and are the main limiting factors for its widespread clinical application [11] . e entire human body is a complex network, and the occurrence and progression of a disease are the results of the comprehensive action of multiple factors. Single-targeted therapy cannot meet the needs of multitarget and multipathway treatment of diseases. e network pharmacology concept put forward by Hopkins in 2007 [12] provides a "multiway" and "multitarget" approach to drug analysis. It is similar to the thoughts of TCM compound prescription, as well as the characteristics of the overall TCM compatibility and comprehensive and multipathway treatment of diseases. e present study employed network pharmacology and molecular docking techniques to establish the active components of SMP in AGA treatment and predicted the potential target and drug action pathways of SMP. Collectively, we aimed to explore the potential mechanism of action of SMP and provide a reference for pharmacological research and clinical application of this prescription. e specific flow chart is shown in Figure 1 .

Rhizoma Atractylodis (Cang Zhu), Cortex Phellodendri (Huang Bo) , Radix Vladimiriae (Niu Xi), and Semen Coicis (Yi Yi Ren), SMP components, were acquired from the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP, http://tcmspw.com/ tcmsp.php), capturing all the potential active components of drugs in SMP. We screened the active compounds in SMP following the standards of oral bioavailability (OB) ≥30% and drug-likeness (DL) ≥0. 18 . en, a search was undertaken for corresponding targets of active compounds on the TCMSP platform. e identified drug targets were input into the UniProt database (https://www.uniprot.org/). To obtain the abbreviation of the human gene for each target, we set the protein type as "Homo sapiens."

e search for target genes related to AGA was achieved using the terms "acute gouty arthritis" and "Arthritis, Gouty" in the Human Gene Database (GeneCards, https://www.genecards.org/), Online Mendelian Inheritance in Man (OMIM, https:// www.omim.org/), the Pharmacogenomics Knowledge Base database (PharmGKB, https://www.pharmgkb.org/), Drug-Bank database (https://www.drugbank.ca/), DisGeNET database (https://www.disgenet.org/), the erapeutic Target Database (TTD, http://db.idrblab.net/ttd/), and Comparative Toxicogenomics Database (CTD, http://ctdbase.org/). e results of the above databases were integrated to obtain the target genes of AGA after deleting the repeated genes.

We intersected the targets regulated by active compounds in SMP with the disease target genes of AGA. After that, common targets were obtained. e R 4.0.2 software and its Venn diagram package were employed to generate a Venn diagram of the SMP-AGA-related target.

e potential targets and active compounds corresponding to the potential targets of SMP in AGA treatment were introduced into Cytoscape 3.7.2 software. en, we constructed the network of "TCM-active compound-potential targets" and conducted the visualization display.

e intersection target was imported into Cytoscape 3.7.2 software. e PPI network was constructed via its plug-in BisoGenet with the following data sources: DIP, BIOGRID, HPRD, BIND, MINT, and INTACT. e plug-in CytoNCA was employed for topology analysis. en, the degree centrality (DC) betweenness centrality (BC) of each node was calculated. A larger DC and BC of the node at the protein location implied that the protein was more important in the constructed PPI network [13] . Because we screened out various important target proteins, other protein interaction parameters, such as closeness centrality (CC) and eigenvector centrality (EC), were further applied to screen core target proteins.

e ID of the intersection target was obtained using R4.2.0 software and its "org.Hs.eg.db" package. en, the "clusterProfiler" and other program packages were adopted for GO functional enrichment analysis of the target. A histogram was constructed after screening out the first 10 functional categories of biological process (BP), cellular component (CC), and molecular function (MF). e target proteins were subjected to the KEGG enrichment analysis, whereby the first 30 KEGG pathways were selected to construct the histogram. Information of the first 20 KEGG pathways was introduced into Cytoscape 3.7.2 to draw the KEGG pathway-gene network map. After that, we selected a signal pathway closely related to GA for visual display.

Docking.

e 2D structure of the potential compound was retrieved from PubChem (https://pubchem.ncbi.nlm.nih. gov/). For small molecules, their energy was minimized using ChemBio3D 2014 software. e 2D structure was converted into a 3D structure. We downloaded the 3D structure of the core target protein from the Protein Data Bank (PDB) database (http://www.rcsb.org). Using the Pymol software, the target protein receptor molecules were processed, including dehydration and removal of ligand small molecules. e target protein receptor molecule was hydrogenated using Autodock Tools 4.2.6 software. e center coordinate and size of the box were set based on the position of the active site of the protein molecule and the area where it potentially acted on the ligand small molecule. Molecular docking was achieved using AutoDock Vina, whereby lower binding energy depicted a better affinity between the receptor and the ligand. e binding energy ≤0 kcal/mol indicated that the compound could bind and interact with the target, whereas the binding energy <−5 kcal/mol demonstrated a very strong binding force. e docking results with the best binding force between each core target protein and active compound were simultaneously presented in 2D images and 3D structures. and their abbreviations were obtained. Information of active compounds and the number of action targets of TCM in SMP are outlined in Table 1 . rough a search in GeneCards, OMIM, PharmGKB, DrugBank, DisGeNET, TTD, and CTD databases, 1,204 target genes associated with AGA were obtained ( Figure 2 ).

Corresponding Active Compounds of SMP in the Treatment of AGA. e drug-disease intersection target (the potential target of SMP in AGA treatment) was obtained by intersecting the 203 drug targets with 1204 disease targets using R software, with 95 potential targets ( Figure 3) . Notably, 33 active compounds corresponded to the 95 potential targets. ey were the active compounds of SMP in AGA treatment.

Target of AGA Network. We drew and analyzed the potential targets of SMP in the treatment of AGA using Cytoscape 3.7.2 network drawing software.

en, a PAC-potential target network diagram of SMP for AGA treatment was constructed ( Figure 4 ). e network diagram comprised 133 nodes (including 95 target genes, 33 drug active components, 4 TCM, and 1 disease name) and 250 edges. We further calculated the degree of the compound in the figure. Notably, a higher degree implied that the compound played a more critical role in the network. e top six active compounds included MOL000098-quercetin, MOL000422kaempferol, MOL000173-wogonin, MOL002714-baicalein, MOL000358beta-sitosterol, and MOL002662-rutaecarpine, with 79, 30, 21, 18, 12, and 7 as the corresponding target numbers, respectively.

Determination of Core Targets. After obtaining the potential target genes, they were imported into Cytoscape 3.7.2 software. We then drew the PPI network diagram using the Bisogent plug-in and obtained 5,264 nodes and 133,011 connections ( Figure 5(a) ). For the first topology analysis, DC ≥ 74 and 982 nodes and 43,726 connections were obtained ( Figure 5(b) ). e second topology analysis was conducted with BC ≥ 925.611 (average), CC ≥ 0.581 (average), and EC ≥ 0.096 (average) to identify the crucial target genes; eventually, 54 nodes and 829 lines were obtained. Target proteins with the top five degree values were selected as the core target proteins in the protein network ( Figure 5 (c)), where TP53 protein, FN1 protein, ESR1 protein, CDK2 protein, and HSPA5 protein corresponded to 946 edges, 781 edges, 1,762 edges, 687 edges, and 445 edges, respectively.

For GO analysis, BP, CC, and MF were included, and 1,938 items were obtained via BP enrichment analysis (including response to lipopolysaccharide, oxidative stress, reactive oxygen species (ROS), etc.); 36 items via CC enrichment analysis (including RNA polymerase II transcription regulator complex, protein kinase complex, and membrane raft); 145 items via MF enrichment analysis (including DNA-binding transcription factor binding, heme binding, and RNA polymerase II-specific DNA-binding transcription factor binding). To draw the GO function histogram of SMP in AGA treatment, we selected the top 10 BP, CC, and MF results at P < 0.05 ( Figure 6 ).

To further elucidate the pathways regulated by the therapeutic target genes, we did a KEGG pathway analysis. Results revealed that these target genes were distributed in 155 pathways. To construct a histogram, the pathways with the top 30 enriched genes were selected (Figure 7 ). GArelated pathways were mainly associated with IL-17, TNF, p53, and HIF-1 signaling pathways. We also analyzed the association of the top 20 pathways with their corresponding target genes by constructing a KEGG pathway-gene network diagram ( Figure 8 ).

ere were 83 nodes (including 20 pathways and 63 target genes) and 403 lines. Based on the number of regulatory pathways, the top five genes were RELA, TP53, MAPK1, IKBKB, and CHUK with 16, 15, 15, 15 , and 15 regulatory pathways, respectively. A strong relationship existed between GA and inflammation (the IL-17 pathway is closely related to inflammation). erefore, we constructed a diagram to demonstrate the association of the regulatory target of SMP with the IL-17 pathway (Figure 9 ).

Using the AutoDock Vina software, PACs in the network map of "TCM-PAC-potential targets of AGA" were docked with five core target proteins (TP53, FN1, ESR1, CDK2, and HSPA5) in PPI. A higher binding activity between the compound and the target protein receptor implied lower binding energy. Results demonstrated that the docking of 33 active compounds with the 5 core target protein receptors was less than 0 kcal/mol (a majority was less than −5 kcal/mol) ( Table 2 ). e molecular docking results of the compounds with the highest binding energy corresponding to the five targets are displayed in 2D images and 3D structures ( Figure 10 ).

e repeated attacks and protracted course of acute gouty arthritis can lead to joint swelling, deformity, and destruction of bone and joint cartilage. Tophi can be formed in many parts of the body, and it could seriously invade joints, kidneys, and even aorta and heart valves in severe cases [14] [15] [16] . For the treatment of gout, anti-inflammatory analgesics are mainly used in the acute stage. After the pain of patients is completely relieved, the use of uric acid-lowering drugs to correct the serum uric acid level is adopted [7, 17, 18] . Studies have found that although febuxostat and allopurinol can effectively reduce blood uric acid levels, they can also increase the risk of cardiovascular disease [19] . Traditional Chinese medicine compounds could function in anti-inflammatory analgesics and lowering uric acid at the same time, which has certain advantages compared with anti-inflammatory analgesics alone [20] [21] [22] . Besides, its relatively fewer adverse reactions and lower price have attracted more and more scholars' attention.

According to Figure 4 , the key active components of SMP in the treatment of GA were quercetin, kaempferol, wogonin, baicalein, beta-sitosterol, and rutaecarpine. Quercetin is the active compound of Cortex Phellodendri (Huang Bo) and Radix Vladimiriae (Niu Xi), kaempferol is the active compound of Radix Vladimiriae (Niu Xi), wogonin is the active compound of Rhizoma Atractylodis (Cang Zhu) and Radix Vladimiriae (Niu Xi), baicalein is the active compound of Radix Vladimiriae (Niu Xi), beta-sitosterol is the active compound of Cortex Phellodendri (Huang Bo) and Radix Vladimiriae (Niu Xi), and rutaecarpine is the active compound of Cortex Phellodendri (Huang Bo) . Among them, quercetin and wogonin are the common active components of two traditional Chinese medicines, which is similar to the compatibility and synergism of TCM compounds. Considering Semen Coicis (Yi Yi Ren) as an indispensable TCM in this prescription, the active ingredient stigmasterol, characterized by a great degree value in Figure 4 , was established as one of the crucial active compounds.

ese PACs in SMP have a certain curative effect on inhibiting inflammation and lowering blood uric acid level [23] . Among them, quercetin, baicalein, wogonin, and rutaecarpine showed strong anti-inflammatory effects [19] [20] [21] . Baicalein could inhibit the activity of NF-κB and some inflammatory factors, such as monocyte chemotactic protein-1 (MCP-1), interleukins, tumor necrosis factor, and cellular adhesion molecules. In addition, it also clears the reactive oxygen species (ROS) to show anti-inflammatory and antioxidant effects [24] . Moreover, wogonin, a flavonoid from medicinal plants, has shown various biological activities. It potentially inhibits the production of inflammatory mediators by macrophages and lymphocytes [25] . Inhibition of NF-κB and mitogen-activated protein kinase (MAPK) pathways in rutaecarpine-derivative R3 inhibits the NLRP3 inflammasome activation, which Figure 4 : A network of the drug-PAC-potential target of AGA. e left circle represents the active ingredients. Different colors distinguish drug sources of each ingredient; blue represents the active ingredient from Cortex Phellodendri (Huang Bo), yellow represents the active ingredient from Rhizoma Atracylodis (Cang Zhu), orange represents the active ingredient from Semen Coicis (Yi Yi Ren), green represents the active ingredient from Radix Vladimiriae (Niu Xi), and purple represents the common ingredient of various drugs. e square node on the right denotes the target.

consequently lowers the expression of proinflammatory cytokine IL-1β [26, 27] . e pathogenesis of GA is highly associated with the inflammatory cascade induced by the activation of the inflammatory bodies of NLRP3 [2] . us, the inhibitory effect of rutaecarpine on the inflammatory body activation of NLRP3 may influence GA treatment. Besides, quercetin and kaempferol may significantly elevate the total antioxidant capacity and inhibit the xanthine oxidase (XOD) effect in hyperuricemia rats [28] . In another study, inhibition of XOD activity could reduce the serum uric acid level and the formation of ROS, consequently reducing the deposition of gout urate crystals [29] . Additional studies found that quercetin could reduce serum uric acid levels in hyperuricemia mice and impede renal insufficiency. is was achieved via the regulation of renal organic ion transport protein and uromodulin, and demonstrated fewer side effects than allopurinol [30, 31] . Betasitosterol (SIT), the main compound among various phytosterols, can reduce the expression of chemokines and inflammatory cytokines. It then regulates various biological HIST1H3I  SMC1A  HIST4H4 HIST1H2BD   EEF1AKMT3  RBM45  NUDT21  KPNA4  HIST1H4E  RAPGEF2  MARCKS  GIGYF2   SUMO3 LUZP1 USP37 SRSF9 LUC7L2   YEATS4  WIZ  PPP1R12A  HIST1H2BI   KAT6A  BAG1  SPICE1   C2CD5 H3F3A  TCOF1 GNL2 RSL1D1  RPRD1B  DYRK1A  NCAPG HIST3H3  SCO2   RBM7  TBC1D4 MYOD1   ZNF24  TRRAP  TAF7  WDR82  SYMPK USP39   KPNA6 KMT2C  H3F3AP4 HIST1H1A   TRIM25 BCOR   SLC9A1  ALYREF   RBL2  HIST2H3D LLGL2 PRMT8   SMARCAD1  TADA3 GTF2B   H3F3B  SRRM2 MCM3 RAD21  PUF60 EIF2AK2 HIST1H3A  HIST1H3E ID2  HIST1H4F RPL13 DDX21  MAGED1  COPS6  CAMKK2  CSNK2A3  RPA2 CCT4 TOP2A  BCAS2 CUL4B  DDX17  HNRNPR EZH2  KIF5A  MCM5  RAE1  SRP14 TNFRSF14   HNRNPA0   EIF2S1 GBAS MEPCE TUBA4B CEBPZ   BRD7 LMO2  SNIP1  HERC4 PIAS2  EDF1  ING4 ATRX  TFAP4  TDG  GLI1  UBE2O COPS7A   MAP1S FOXO1 MEN1 MAX   PELP1   HNRNPAB   BTBD10 SBF2   MEF2D  ZNF496   PSG1   NEIL3  OGG1 TPP1  TOE1  NAT9   FOXR1  FLYWCH2  EP400  TEX11   LZTR1   CDYL   ARPC5  RBM5 KDM4B YTHDF2  SNRPN MSL2  MLLT1  MAGEA11   LRWD1  PCGF2  NR2E3  KAT2A EID1  ANAPC7  FAM193B   DMAP1  SRP9  GLYR1  MED21 CEBPB  CETN2 SIN3B   NKX2-1  CXXC1  ARID4A  POLR2I  CDCA7L TONSL  ARHGEF1  EPC1  DBF4 RTF1   COPS8 BRD3  POLR2H   UBASH3A  MED10  RPP30   CCNK   ZFP91-CNTF   THAP12   PRCC  TAF6  NSD1  VAMP8  MSL1 NSD2  ORC2  CHD7  SATB1  GTF2F1 POLD1  DHFR  PRRC2C ZNF219  PDLIM1 LGALS7B SPIN1  PRPF4B SMARCA1  RBM17  TOPBP1   RNF4 ATXN2  PFKL  SUPT20H  S100A7 ANGPTL4  MIF4GD CIAPIN1  HIRIP3  HIST1H2AB  G3BP2 RBM15   XPC USF1  TRAF3IP2  FMNL1  PPP1R8  WDR33  RNGTT  PHLDB2   HIST2H2AB   CDK7   POLR2K  TAF10  MYLK2 CARD8   LAMP2  C14orf166  LBR  RAD50 MDN1  TOB1  HIST2H2AA4 FOXQ1   MRPL53  WDR18 CHAF1B RFX5TOX4  MED6  RNF146  STK38   SNAPC1 PFKFB1  IL2RA  NKX2-5 

LGALS7 BTBD2 HIST1H2BB  KMT2E  MOV10 MKNK2   GTF3C2   RBM28   RPF2  ANXA6 PHF20  ARID1A  TAF2  PAX5   TAF1C  ING3  LYL1   ZNF302  MRPL43  CPSF3 DDX52 METTL13   L3MBTL2 TAF1A  TARBP2 CHD1   CSTF1   CAMSAP3 MBD3  TFDP3  RPRD1A  ANAPC4  ZSCAN1  RFC1   CCAR1  HIST1H2BL   PHLPP1  SGSM2  LDB1  KIF26B  CDC7  MAGEA2 ESPL1   KDM4C  LIG3  GEMIN2   GTF2H1 DTL  CBX1  KCND3  POLR2E   PPP2R5C   CCNT2   LIN54   KAT6B   FNDC11  TFDP2  TSPYL4  BDP1  DUSP6   CACNG4   DLX5   BUD13 SMA4  APITD1-CORT  KDM4D   YY1AP1   RFPL2 NFIX  GTF2A2   ACY1 CCNO  STAC3  TRIM6-TRIM34 CCDC106   ZNF420   TSTD2   PATZ1  DUSP7 ELK3  CREBZF   HOXC9   HMGN2   TXNRD2  MSX2 BATF3   MECOM  MAFF   DUSP9  RPA4   TRIP11  SULT1E1  ANKZF1  FBXO4   GTF2H4   TAF5L  SERPINB4   IRAK1BP1 KEAP1  EIF2A  CDC45  TRIM24  ZNF131  HIST2H2AC  MORF4L2 POLR2G  DCUN1D5  RYBP  FOXM1   PIAS3  SKP2  PPP2R5D ARIH1  NFATC1 MARK3   CDC73  RNF114  PPARD FKBP3  LOC100996724 PKN1  FBXW7   RARA CHFR PPFIA1  DHX36  SETD7  CDC25A GPS1  MRPL28 CDK3 POLA2  NSD3  SHMT1 HRNR  CREBBP PPID  HIST1H2AA MRGBP  PCBP2 SPEN  CCNE1  SMARCD2 TFIP11 WDR26 DACT1  NR1H2 DRG1  PIAS4  PPARG   NAF1  ATF3  S100B  SIRT2 BOLA2  MED14 E2F4  NCOA3   CENPB  BAG4  BANP  APPBP2 RUNX1  HEY2 RXRA  ANAPC2   RXRB NEFM   CPSF1  TTI2  FANCC  VTA1  EIF4E2  STAT6  HIF1AN  GTF3C3   TOPORS NKD2  AKAP8  CSTA   RBFOX2   SMARCA2 KAT8 OLA1 CNOT9  AMOTL2  BLM  HIVEP1 JUN  NR2C2   PGR  CBX2  KAT2B   CCND3  CCNT1 DDB2   ERCC6   MCM10 YY1 HIST2H3C AKAP8L TBP  CREB1  SNAI1  NCOA1  FOXO3  CRIP2 NOL3  SMARCD3  TSPYL2 KMT2A   AKAP5  RBM3  PPP2R2A HIST2H3A DCAF1  RNF41  MORF4L1 TLE1  SSX2IP   HIST1H2BA KMT2B DEUP1  WDR5   CEBPA  CDK8 DNAJC9 PSPC1  NRIP1  ADNP TUBB1  TCEAL4  AGO1   POM121 CDC27  KLC2  RCOR3  RB1   FTH1  COPRS  SMAD7   TAF12  POU2F1  ID1  MYL12A ERC1  MEF2A  CEP70  E2F1  SPOP KAT7 RUNX2   TAF1 PGAM5 PSMD5 ORC4  EEF2K  XRCC5 HIST2H4A  HIST1H3H MED23 FLNB CCNB1   FLAD1  HIST1H4H  HAUS1   TERT   NFATC2   PARP1   TP53  BARD1 TSSC1  H2AFX DNAJA3  UBE2I  TRIM28  HNRNPK  STK4  PHC2   TP53BP1  RRM1   SMARCA4  HIST1H4B MAD1L1  HIST1H4J CDK9  STXBP1  KDM5B SIN3A   KAT5  ATM  HIST1H4K EEF2 KRT5  BRMS1  DHX15 DDB1 HDAC1  DAXX  SLC25A1  TJP1 CC2D1A  GATA2 PPARGC1A  NCOA6 EIF4EBP1 AKAP13   CCNG1  PRNP  IRF7 KMT5A  FZR1  CHD8  PRKD1  FIP1L1   NCF1C MTF2  AXIN2 ZBTB33 JUND  RFFL   TFDP1  CCND2 TULP3   MRM3  LOC100653061   MLKL  TTC3  EPSTI1  E4F1   ITPK1  ACTL6B HSPB6   FIBP  TLR2  NFYC  GMNN   NRBF2  KLF10 IKZF4   RANBP3  GPR37  SERTAD1 RLIM  KIDINS220   USP12 BTG2  ERF  HBP1  SLK  TRO   SASH1   PRDM1  PPP2R5E   CDX2   CDKN1C METAP2   RAD54L2   EHHADH CPNE7  ZSWIM8  EHMT1  EGR1  BCL6  SENP1  FBXO18 ETV1   RASSF1 NEXN  PPIL1  EPAS1   NTRK3  IL6ST IER5   IL16   RAP1GDS1   PPM1D  TMEM62   SOCS2  CTBP2  PRKAA2  ANKRD17   MGEA5 WASL   MAPKAPK3  CDC25C   LANCL2   MYL6B   TCL1A   PACSIN1 IFNGR1  PAX2  MNDA  ZBTB25  MOAP1 IL15RA  NSMCE4A   MAGEB18  TNNI3   SPTB TH   MED24   ENC1   MUL1   C7orf25   CCNB2   DACH1   NAV1  NR1H3   ESRRA   WDR83   MAPKAPK2  RAC3   CA2   RNF126 ETF1  MAP3K5 NUP35 NFATC2IP  MTA3   PIAS1   MINK1  HMMR SAFB2  CCND1   CD82   KCNIP3   KRT7  MYH3  NOTCH4   ITGB6 ABHD16A  COL3A1   ST14  DPYSL5  EDA2R   IP6K2  NPPA PTPRR  SELE   IL13RA2  ROBO1   PTPN7   PRTN3  IL18   XAF1   LURAP1L   KLK2   TRAPPC13   ITPKA   MYL3   INPP5B   STYK1   PPFIA4   ASRGL1   KRBA1   DUSP2   HOXA5  TBC1D2  TRAPPC11   CHD9   SRMS   DENND5B   ARHGAP9  HIVEP3   IL27RA   MINPP1   ALOX15B   GUCY1B3   RGS22   ZNF212 ARID5A  TRIB1   GREB1 MFAP4  DUSP4   ANKRD2 HOXB2   NLRC5  CNKSR1  CYTH3  PTPRCAP   CER1   REG3A   NBEAL2  EYA1   TRIM40   NLRP10  ITPKC  DUSP22   IQCG   ZNF467  USP31  ANKRD6   ACSBG1   MPO   AGBL2   AK4  CYTH4   NEB  DEC1  SERPINA4  USP28  CLEC3B   NEFH   SERPINA1   SDC2   CCDC180   STAT4  TNFRSF10A  ELP2  MYOC   PDGFA  MEF2C METTL3  IRF2  SMAD6 ELK1  PRKAR2A  IFNAR1   SOX4  PPP3CC   THRSP   PDK3  LEF1   TICAM1   TLR4  ANKRD13D  PPP4R3A   MXI1  RGS7  ZBTB9   LIPH  STAT2  SUV39H2 PDGFB  PSMC3IP IL2RG IL12RB1   ZNF133   VWF   GALNT12   INCA1   SDC4  JMJD1C   RNH1 RRM2B   ITGB5  TRIB3 CHAF1A ARHGEF5  AKT2CDKN2C LDOC1 POLL  PRMT2   MAPK14  RRM2  NOTCH1  RIPK2  MNAT1  IKZF3  MED12   NR1H4  NR4A1 ATXN7   CASP9   PSMC5  MAPK8   SMAD4  BIRC2  DYNLT1 SMAD9  CDKN1B CPSF7  CDC25B   FOS   AP3M1  ATN1 PPP4C  STAT3  SNCA   MBP  GRIP1   PRKAR1A  NEK2 BRAP  STRAP  ZBTB17   UBE2E2 STK24  ELOC   GSK3A  PCBD1  STAT5A  BRCC3 PPM1A  MYEF2  AXIN1   ARPC2 CDK11B  HIST1H1B  TRIM39  RB1CC1  DVL1   FADD  TRIM54  TNFAIP3 USP4  TCERG1  ZBTB8A EPN1  PTPRS FHL2  HIPK3  DST  LOC400927-CSNK1E RGS3  ITK  PTPN12  MAP2K3   FGR  RABGEF1  PLG   HCLS1  HLA-DRB5 IL1A   CCL2   CRTC2   MRPS34   SOS2   GABARAPL1 APPL1  FEN1 DPYSL2  EIF4A2   HES1 NFKBIE   KRTAP10-7  OPA1 TIAM1   DDX6  DDX58 ETS1  PPP2R5A   FBXL12  CORO7  LCK   TGFB1  LIMK1  PIK3CA  ARFGAP3 MYO5A  HIPK2   KSR1  GZMB  PTGS2   CDKN2A  TRAF2  S100A8 WWOX  USP2  RBX1 DSP  DAPK1  STAT1  GSK3B SF3B2 HIF1A  UBE2S UBASH3B  RAB11B  MAPK3  TMEM63B   KHDRBS1  YWHAB FOXK1 CDC42 ANXA2 TGM2  SH3KBP1 UCHL5 RET DNAJC7  MAPK1   RNF43  BRD4  EIF3D GLUL MAPK9  SLC2A1 TMOD1 RFC4   STAT5B  PSMA4 DNM1L  JAK1 PAK1  NEDD4 MAP3K7  IRS4 AP1B1 OTUD4 GRB7 TFCP2  NAA10  SMURF2 CDH1  WAS ELOB   TFAP2C  TMX2-CTNND1 CCL5  PTPRO  CHST10  SH2D1A TNFRSF25  NPDC1   IDSTHBS1  AAK1   FRAT1   ARID3A  COMT  CRADD  HBEGF  ATP2B2  TMEM185A   SNTB2 DOK1  PRKCQ  EXOC7  RGS20  FBP2   TLDC1   GRB10  ZNF510   ADAM15   CPNE6   FES  CARD11 ALPP  VRK2 BAD PTPN6  PECAM1   SH2D2A  CREM  ARNT2  CARHSP1 CISH  SPTLC1 CTSG   CDC34 TFAP2A  DHFRP1   NEK9  TRMT2A  RPS6KA2  TSC2  ARIH2 C11orf84  WAC  ARAP1  KDM2A KRAS  MAPK12   MAP2K2  RNF14  ASB15  IRS2 PTPA   MAP2K6  MAP2K4   NUMB  RCHY1  BAIAP2 ARPC3   SPAG9  LAMTOR5  PARK7 SOCS3  PALLD  ASXL1  KCTD13  PDGFRA   PRKCD  SORBS3  MLH1  FHL1 RAP1B   GABARAP  PFKP VAV1  DYRK1B PLAUR PRKCZ  FBXO11 HDAC8  ACTN2  ADRM1  TNNT1  MEOX2  CASP7 MAPK7  RPS6KA4  PFN1 NR2C1  PLCG1   ITCH  CREB3  CSNK1E MAP2K7   MAP2K1  CTNND1 SEC61B   ERRFI1 CAST  OXSR1 CASP6   BUB1 MALT1  NCKAP1   WWP1 JAK2 IL2RB  PTPRJ   PGD CLTCL1  RAB14  TMED9  SEC24C  PPP3CA  ATP2B1  MAVS   ALDH3B1 MAPK11 TNIP1  PKMYT1  FBP1  SIAH2 AK2  CD19  PFDN2  CASK  TPX2  LMO4   SNAP29  KRT10   NME5  ATRNL1   ACKR1   SPOCK3 MMP10   MMP8  TMPRSS6   CCR2  PZP   TNFRSF11B  MMP1  BCAN   ADRB3 ACAN   GNA14   CMA1   CCR1   ITGAD   CXCL2  LTBP1  COMMD10   ADCY5 COL4A6  PCOLCE  KSR2  ARRDC3   COL7A1 MMP9   GABRR2  PSENEN  IFNAR2   PROC MAP3K21   KLK3EDNRB  PTGS1   TFPI  NEK11   PPP2R5B   C1QB   IL1B   SEMG1   KRT86   ITGA3 C9orf3  APBA2  CAPN7  ELANE  PTPRE  RGS11  DOK5  NKIRAS1   CNKSR2  C4A  DZIP1 CTSV BAAT  GRIN2A RCAN1   C6   ANK1  DNAJB12 LAMA1  SOS1   CPB2  ACKR2   RNASE1  MMP17   FSTL3  CCR3  COMP   HAPLN1   THBD   FGG  BNIP3L UCK2   GLCE   HOXC10  SH2B2  MCAM  PRKCH  NCAPG2  SRGN PAK6 ROBO2  RASL10B   CEBPG  STK40   RHOBTB3   LRRC1  PPIL2 PTK6 RASGRF1   IL24  FBXO21   RRAS2   PHF1  WT1 KLK9  HEMGN  ERAL1 OTUD7B   GAS2L1   MICALL2   TMEM54   CDC14B   ATPIF1  USP24  DFNA5   FGFR4   WSB1   GNG11   EGLN3  ZBTB24 C3   FAM175B   SCAMP1   PLK3   CAMK4   PPARGC1B  BMPR1A  AREG  GJA1   ERCC3   SHARPIN PATJ   CSF3R   FER UBXN11   MLH3   ETV3  ADH5  ZNHIT1   MAP3K2   GFI1  STK39  DUSP3  DEDD  RNF34   RNF38  NOXA1  AGER   SYCE1   LACRT   APBA3  ARG1  GRM7   ATF1  OTUD5  PPP3R2  COL4A5   REV1  ANKHD1  STAP2   DGKZ   GNB4  ZFYVE9  PRKCSH   CXCR4  TNK2  ANXA5 BID ARRDC1 CSK   CAMK2D FGFR3   USP33  PRKCE  MAP2K5 BTK  ENAH EPS8  RBCK1  EIF1AX  PRKCB PTK2 OS9 MAP4K1  ERBB2 TEPSIN  P3H1  MLST8  GNB5  CABLES1 FASLG  CASP10  MUC1  INPPL1  SORBS2 BIRC7  TNPO1  BIRC3   ITGB1  KRT16   LOC653513 TSN ATG12   TOM1L1  KRTAP10-3 UXT  TPT1  PIK3R1  BCAP31  STAM2  PTK2B  GSN  DAB2  GNB2 TPM1  LOC100996717  PPP2R1B KRTAP10- functions, including anti-inflammatory, analgesic, immunomodulatory, and antimicrobial functions [32, 33] . Also, stigmasterol can inhibit the inflammation induced by sodium urate crystals and XOD activity in mice, a phenomenon that validates its antigout effect [34] . Herein, to obtain the core target proteins of SMP in the treatment of GA disease, the PPI network of intersecting target proteins was constructed. Also, we performed two topological screens on the SMP target for GA treatment based on DC, BC, CC, and EC. TP53, FN1, ESR1, CDK2, and HSPA5 were the five core target proteins. Based on the existing reports, TP53, also known as p53, contributes to transcriptional regulation of the cell cycle, DNA repair, cell survival, and cell metabolism [35] . Inhibition of p53 exerts a substantial effect on promoting the senescence of IL-1β-induced chondrocytes [36] . e potential role of TP53 in the regulation of inflammation has been described, whereby it significantly inhibits the production of proinflammatory factor IL-6 [37] . e overexpression of FN1 can activate TGF-Akt/PI3K/Akt signal pathway to promote cell viability and differentiation capacity [38] . Cyclin-dependent kinase (CDK) is the main regulator of cell division. It can be potentially triggered by different cyclins at different cell cycle stages [39] , and it can regulate the secretion of inflammatory cytokines in macrophages [40] and inhibit CDK2. In consequence, a reduction in chemotaxis of primary neutrophils outlines the role of CDK2 in regulating inflammation [39] . Estrogen receptor 1 (ESR1) is a subtype of human ESR, expressed in chondrocytes, stromal cells, and osteoblasts [41] . In particular, ESR can induce the transcription of related target genes to promote the proliferation and differentiation of tissue cells as they bind to estrogen [42] . Heat shock protein family A member 5 (HSPA5) gene can also participate in the inflammatory process of various types of osteoarthritis as it encodes the binding immunoglobulin protein (BiP) of the endoplasmic reticulum Hsp70 family [43] .

Following the KEGG signal pathway analysis, the mechanisms of SMP in the treatment of AGA were mainly anti-inflammation and protection of the cartilage. e critical inflammatory signaling pathways included TNF and IL-17, whereas the apoptosis signaling pathways included p53 and HIF.

Current pieces of research on the mechanism of gout have reported that the phagocytosis of MSU crystal triggers the change of inflammatory cell state of synovial cells in GA pathogenesis [14] . For instance, the deposition of MSU crystals promotes the local release of TNF-α and IL-1β, which causes persistent gout episodes [44] . IL-17 also stimulates macrophages and monocytes to produce Figure 9 : e IL-17 signaling pathway. e green nodes in the road map denote the genes existing in our SMP network.

Evidence-Based Complementary and Alternative Medicine proinflammatory factors, including IL-1β, TNF-α, and IFNc ( Figure 9 ). As a powerful proinflammatory cytokine, IL-17 can increase serum IL-17 levels 8 hours following the acute attack of gout [45] . Moreover, in several arthritic animal models, the inhibition of IL-17 expression was found to limit inflammation and reduce joint erosion [46] . e TNF signaling pathway has also proved to be a crucial inflammatory signal pathway. Signal transduction is mediated by TNF receptor 1 (TNFR1) and receptor-2 (TNFR2). TNFR2 is, in most cases, expressed in immune cells. It binds to TNF-α and TNF-β to regulate immune response [47] . TNF-α is a proinflammatory cytokine produced by different cell types, such as macrophages, lymphocytes, and fibroblasts, and reflects inflammation, infection, and other environmental stresses [48] . Previous reports showed that inhibition of TNF-α expression in synovial cells during AGA could effectively inhibit local inflammation [49, 50] . e physiological dose of soluble uric acid exerts a specific protective effect on cartilage [51] . However, following repeated attacks by GA, the articular cartilage edge is damaged, the articular surface becomes irregular, the joint space becomes narrow, and MSU deposition occurs [52] . A study found that reduced articular cartilage matrix secretion in patients with GA was associated with chondrocyte apoptosis [53] . p53 can regulate cell differentiation and senescence. e inhibition of p53 expression potentially improves senescence and affects the destruction of IL-1β-induced chondrocytes [36] . Compared to the inflammatory signaling pathway, the HIF-1 signaling pathway is slightly less in gout studies. As a transcription factor, activation of HIF-1α expression in synovial cells may be induced during hypoxia. Synovial hyperplasia follows the repeated infiltration of inflammatory cells in the joint. On the other hand, hypoxia is associated with immune cell infiltration and synovial hyperplasia. erefore, the upregulation of synovium-derived HIF-1α occurs in the pathogenesis of rheumatoid arthritis (RA) and osteoarthritis (OA), which are hypoxia-associated diseases [54, 55] . HIF-1α exerts a regulatory role in the function of immune cells. Activated LPS-induced macrophages can also express HIF-1α, which is crucial in glycolysis and the induction of proinflammation [56] . e therapeutic effect of SMP on AGA may be derived through the regulation of the inflammatory signal pathway, p53 apoptosis signal, and HIF-1signaling pathway. And other top-ranked signaling pathways, such as the AGE-RAGE signaling pathway in diabetic complications, fluid shear stress, and atherosclerosis, etc., still lack their gout-related studies, which are Evidence-Based Complementary and Alternative Medicine likely to be the future direction of gout mechanism research. According to the space matching and energy matching relationship between molecules, the core target protein of SMP in AGA treatment was docked with active compounds. is provides a reference for the subsequent research and development of targeted drugs. e 2D image of molecular docking depicts the binding mode between the core target protein and the compound as well as the interaction with the surrounding amino acid residues. Hydrophobic interaction best describes the main association of target protein TP53, FN1, and ESR1

with Inophyllum E. e target protein CDK2 residue Leu83 (A) forms a hydrogen bond with Inophyllum E, whereas the residues Asp34 (A), Lys96 (A), r37 (A), and Gly227 (A) of the target protein HSPA5 form five hydrogen bonds with baicalein.

e main forces between ligand and protein are hydrophobic force and hydrogen bond, which both are chemical bonds with strong binding force. According to Table 2, key components of SMP have strong binding activity with core target proteins, such as TP53, FN1, ESR1, CDK2, and HSPA5, suggesting that SMP may play its pharmacological role by regulating these key targets. However, there are still some Evidence-Based Complementary and Alternative Medicine shortcomings in this study, and the conclusions need to be further verified by in vivo, in vitro, and clinical trials.

e present study systematically expounds the core compounds and molecular action mechanism of SMP in the treatment of AGA. e core compounds of SMP, including quercetin, kaempferol, wogonin, baicalein, and beta-sitosterol, were screened via network pharmacology, whereas the core targets of AGA including TP53, FN1, ESR1, CDK2, and HSPA5 were screened out via PPI. ese core compounds are characterized by stable binding activity to the core targets. Also, SMP could regulate signal pathways related to AGA disease, for example, TNF, IL-17, p53, and HIF signaling pathways. ese findings suggest the potential synergistic role of SMP in treating AGA via multiple components, multitargets, multiple biological functions, and multiple signal pathways.

What makes gouty inflammation so variable?

Gout: state of the art after a decade of developments

Epidemiology of gout in Hong Kong: a populationbased study from

Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey

Trans-chalcone attenuates pain and inflammation in experimental acute gout arthritis in mice

American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis

Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective

Colchicine: risk of severe toxicity and death from drug overdose

Integrating network pharmacology with molecular docking to unravel the active compounds and potential mechanism of simiao pill treating rheumatoid arthritis

Simiao decoction alleviates gouty arthritis by modulating proinflammatory cytokines and the gut ecosystem

e effects of modified simiao decoction in the treatment of gouty arthritis: a systematic review and meta-analysis

Network pharmacology

Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease

Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis

erapeutic approaches in the treatment of gout

Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study

Review on the potential action mechanisms of Chinese medicines in treating coronavirus disease 2019 (COVID-19)

Developments in drug delivery of bioactive alkaloids derived from traditional Chinese medicine

Insights into the action mechanisms of traditional Chinese medicine in osteoarthritis

e genus Achyranthes: a review on traditional uses, phytochemistry, and pharmacological activities

Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells

Natural products as a crucial source of anti-inflammatory drugs: recent trends and advancements

Chinese herbal medicine si-miao-san decoction for acute gouty arthritis: a protocol for systematic review and meta-analysis of randomized controlled trials

erapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders

Potential therapeutic and pharmacological effects of Wogonin: an updated review

e inhibitor effect of RKIP on inflammasome activation and inflammasome-dependent diseases

Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport

Effects of parsley (Petroselinum crispum) and its flavonol constituents, kaempferol and quercetin, on serum uric acid levels, biomarkers of oxidative stress and liver xanthine oxidoreductase aactivity in Oxonate-induced hyperuricemic rats

erapeutic efficacy of urinile against gouty arthritis

Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice

Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver

β-sitosterol attenuates the intracranial aneurysm growth by suppressing TNF-α-mediated mechanism

An update on β-sitosterol: a potential herbal nutraceutical for diabetic management

Lychnophora pinaster ethanolic extract and its chemical constituents ameliorate hyperuricemia and related inflammation

What 20 years of research has taught us about the TP53 p.R337H mutation

GPR39 agonist TC-G 1008 ameliorates IL-1β-induced chondrocyte senescence

p53 predominantly regulates IL-6 production and suppresses synovial inflammation in fibroblast-like synoviocytes and adjuvant-induced arthritis

FN1 promotes chondrocyte differentiation and collagen production via TGFβ/PI3K/Akt pathway in mice with femoral fracture

Phenotypical microRNA screen reveals a noncanonical role of CDK2 in regulating neutrophil migration

Immunomodulatory roles of cell cycle regulators

Localization of estrogen receptors alpha and beta. In the articular surface of the rat femur

Polymorphisms in the gene encoding estrogen receptor alpha are associated with osteoarthritis in Han Chinese women

HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum

Phagocytosis of monosodium urate crystals by human synoviocytes induces inflammation

Serum levels of IL-17 are elevated in patients with acute gouty arthritis

Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

Biologics in development for rheumatoid arthritis: relevance to osteoarthritis

Efficacy of Xixiancao (Herba Siegesbeckiae Orientalis) on interactions between nuclear factor kappa-B and inflammatory cytokines in inflammatory reactions of rat synovial cells induced by sodium urate

e effects of carvacrol on inflammatory cytokines and the apoptosis of cartilage in rats with gouty arthritis

Physiological concentrations of soluble uric acid are chondroprotective and anti-inflammatory

Metabolism of crystals within the joint

Suppressive effect of sanmiao formula on experimental gouty arthritis by inhibiting cartilage matrix degradation: an in vivo and in vitro study

Current and novel therapeutic targets in the treatment of rheumatoid arthritis

Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/HIF-1α pathway

Chaetocin attenuates gout in mice through inhibiting HIF-1α and NLRP3 inflammasome-dependent IL-1β secretion in macrophages

Acknowledgments e authors would like to thank Freescience (http://www. home-for-researchers.com) for the help with the English language.is research was financially supported by the National Natural Science Foundation of China (Nos. 

Simiao Powder AGA:Acute gouty arthritis TCM:Traditional Chinese medicine IL-17:Interleukin-17 TNF:Tumor necrosis factor HIF-1:Hypoxia-inducible factor 1 GA:Gouty arthritis ACR:American College of Rheumatology NSAIDs:Nonsteroidal anti-inflammatory drugs TCMSP:Traditional Chinese medicine systems pharmacology database and analysis platform OB:Oral bioavailability DL:Drug-likeness OMIM:Online Data Availability e data for this study can be provided by the corresponding author (Wei Liu: fengshiliuwei@163.com).

ere are no conflicts of interest between these authors.

Yihua Fan, Wei Liu, and Yue Jin have contributed equally to this work and are co-first authors.